戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 odovirus) showed broad-host range, producing bacteriolytic activities against 81.3% (n = 26) and 78.1
2 positive) charge on the catalytic domain and bacteriolytic activity in the absence of the CBD (noncla
3 ogen interactions, such as resistance to the bacteriolytic activity of lysozyme, virulence, and host
4                                              Bacteriolytic activity, as well as strong interactions b
5                         PGRP-L has no direct bacteriolytic activity.
6 ite and are identified to be crucial for its bacteriolytic activity.
7                                   CF-301 was bacteriolytic against 250 S. aureus strains tested inclu
8 th and LYZL2 (p value = 9e-9), which codes a bacteriolytic agent thought to be involved in host defen
9                                              Bacteriolytic anti-cancer therapies employ attenuated ba
10                                          The bacteriolytic character of bacteriophages was employed a
11 g their linker regions, thus hindering their bacteriolytic cooperation and possibly modulating the ly
12                   However, the generality of bacteriolytic effectors and, moreover, of antibacterial
13          Bacteriophages having host-specific bacteriolytic effects are promising alternatives for com
14 uced immune response, when combined with the bacteriolytic effects of C. novyi-NT, could eradicate la
15 lement proteins C3b and C5 and inhibited the bacteriolytic effects of complement.
16 s because of its potent, specific, and rapid bacteriolytic effects.
17 phylococcus simulans secretes lysostaphin, a bacteriolytic enzyme that cleaves staphylococcal peptido
18 phylococcus simulans secretes lysostaphin, a bacteriolytic enzyme that specifically binds to the cell
19                          Lysozyme (LYS) is a bacteriolytic enzyme, available in secretions such as sa
20                PGRP was not a PGN-lytic or a bacteriolytic enzyme, but it inhibited the growth of Gra
21 me in a bacteriophage infective cycle, allow bacteriolytic enzymes, or endolysins, to escape to the p
22 sin, is a direct lytic agent that is rapidly bacteriolytic, eradicates biofilms, and synergizes with
23 ons to confer target cell specificity to the bacteriolytic molecule.
24  response is triggered by membrane-targeting bacteriolytic peptides of different structural classes a
25  Identification of CRISPR spacer matches and bacteriolytic proteins suggests that subsets of picobirn
26            This strategy, called combination bacteriolytic therapy (COBALT), has the potential to add